|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02192 MEDLIVE
Nominal 
9.740 -0.030 (-0.307%) Ranking Overview
Ranking based on 1 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 33.56 RMB (cts) | |
| Net Profit | 242.30 RMB (MIL) | DPS | 23.15 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 297.00 | 40.00 | 24.00 | -- | 297.00 | 297.00 |
| 2025 | 200.00 | 27.00 | 16.00 | -- | 200.00 | 200.00 |
| 2026 | 207.00 | 28.00 | 17.00 | -- | 207.00 | 207.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 297.00 | 40.00 | 24.00 | HSBC | Buy | 11.20 | 04/09/2024 | |
| 2025 | 200.00 | 27.00 | 16.00 | HSBC | -- | -- | 04/09/2024 | |
| 2026 | 207.00 | 28.00 | 17.00 | HSBC | -- | -- | 04/09/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 20/12/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 146,719,000 |
| %Change | 48.624% |
| EPS / (LPS) | RMB 0.202 |
| NBV Per Share (¥) | RMB 6.439 |